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Abstract—In this paper, a novel implantable bioimpedance 
monitor using a free ZigBee protocol for the transmission of the 
measured data is described. The application field is the tissue 
and organ monitoring through electrical impedance 
spectroscopy in the 100 Hz – 200 kHz range. The specific 
application is the study of the viability and evolution of 
engineered tissue in cardiac regeneration. Additionally to the 
telemetric feature, the measured data are stored in a memory 
for backup purposes and can be downloaded at any time after 
an RF link break. In the debugging prototype, the system 
autonomy exceeds 1 month when a 14 frequencies impedance 
spectrum is acquired every 5 minutes. In the current 
implementation, the effective range of the RF link is reduced 
and needs for a range extender placed near the animal. 
Current work deals with improving this range.  
I. INTRODUCTION 
HE electrical impedance technique can be used to 
monitor the tissue and organ state. Multifrequency 
electrical impedance measurements provide information 
about cell viability, density, morphology and intra-extra 
cellular fluid ratio, being thus useful to detect macroscopic 
changes in a tissue [1].    
In cardiac tissue characterization applications, electrical 
impedance spectroscopy (EIS) has been used to detect acute 
ischemia [2], [3], old infarction scar [4] and rejection in 
transplanted heart [5], [6].  Measurements are performed in 
open thorax set-ups [3], through catheter [3], [4] or using a 
pacemaker-type device [5], [7]. 
Our group is involved in research projects with the 
Cardiology Department of Santa Creu i Sant Pau Hospital, 
in Barcelona, with two running applications: non-invasive 
graft rejection detection and regenerative tissue engineering. 
In this last topic, a non-functional myocardium area (eg an 
old infarction scar) is intended to regenerate by using 
myocardial cell precursors derived from stem cells. Our 
group has developed a technique for in-vitro cell culture 
monitoring using EIS with interdigitated microelectrodes in 
a 4-electrode configuration to separate cell-growing and 
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cell-adhesion [8].  
In order to monitor the viability and evolution of the 
engineered tissue after its implantation in an animal model 
heart (pig or sheep), an implantable device should be 
developed. The device should be able to acquire an 
impedance spectrum every 5 minutes in the range  100 Hz – 
200 kHz during 1 month. The design and preliminary results 
of EIS performance, power consumption and RF range are 
presented.   
II. METHODS 
A. Bioimpedance monitor 
The bioimpedance monitor developed measures the 
electrical impedance at 14 frequencies. It stores the data 
collected and transmits them to an external computer. To 
allow us to debug the bioimpedance monitor a first 
prototype has been built over a two-layer PCBwhose 
dimensions are  60 mm x 60 mm. The final system has a size 
of 35 mm x 37 mm and these are mainly given by the 
battery. It is a six-layer PCB with a height of 8 mm, 5 mm 
height of the battery and 3 mm of the PCB with the 
components. 
In figure 1 shows the debug prototype (left) and the final 
system PCB (right). 
 
 
Fig. 1.  Picture of the prototype developed for system debugging (left) and 
the pcb of the final bioimpedance monitor (right). 
B. Power supply 
The bioimpedance monitor is powered from a NiMH 
battery and has two dc-dc converters. The digital circuit of 
the bioimpedance monitor is powered at 3.3 volts whereas 
the analog sub-circuits are powered at ± 2.8 volts. The 
analog supply can be switched on when the bioimpedance 
measurements are going to start. Also the supply of the RF 
transceiver is controlled. When the monitor is in sleep mode 
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the only functional system is the microcontroller 32 kHz 
low-power oscillator. 
The system makes a measurement every 5 minutes and 
remains the most part of time in sleep mode, then increasing 
the autonomy. Figure 2 shows the current consumption 
graph for a measurement period of 35 seconds. When the 
system is in sleep mode the current consumption is 0.2 mA, 
when it is doing a measurement the current consumption is 
35 mA and extents 2.7 seconds. When it is storing the data 
in the memory, the consumption is 1 mA with a extent of 
100 ms and when it is transmitting the data, the current 
consumption is 11 mA lasting 2 seconds. The peaks that 
appear in the figure 2, when the bioimpedance monitor is in 
sleep mode are due to the microcontroller exits from the 
sleep mode, when it looks for commands transmitted from 
the access point. 
 
 
Fig. 2.  Current consumption graph during 35 seconds period.  
 
Considering a mean consumption of 0.588 mA in the 5 
minutes period and using a battery with a capacity of 450 
mAh, the theoretical autonomy of the system is 765 hours 
(32 days). Bigger capacity batteries are available. 
 
C. Bioimpedance measurement system 
The bioimpedance monitor is based in the 12 Bit 
Impedance Converter and Network Analyzer AD5933 [9], 
modified with an analog front-end that implements a 4-
electrode measurement structure and allows to measure 
small impedances [10]. Basically the main modifications are 
the addition of a voltage controlled current source, to inject 
a constant current, a wide-bandwidth differential amplifier, 
and a voltage to current converter plus a voltage shifter to 
adapt to the single supply, 2-electrode structure of the 
device. Figure 3 shows the block diagram of the monitor.  
The bioimpedance monitor is tailored to measure in the 
range 10 Ω to 1 kΩ, at a programmable set of frequencies. 
The initially chosen frequencies are 100 Hz, 200 Hz, 500 
Hz, 700 Hz, 1 kHz, 2 kHz, 5 kHz, 7 kHz, 10 kHz, 20 kHz, 
50 kHz, 70 kHz, 100 kHz and 200 kHz. The value of the 
real and the imaginary part measured is the arithmetic mean 
of 4 measures at each frequency.  
 
 
Fig. 3.  Block diagram of the bioimpedance monitor. 
 
The current injected to the load is limited to 10 μApp with 
a bandwidth of 1 MHz. Figure 4 shows the variation of the 
current injected versus load impedance. At 100 Hz the error 
in the current injected is 3.2% and at 200 kHz if 5% when 
the load impedance is 980 ohms. Part of this error is 
systematic and can be compensated by calibration. 
 The connection of the bioimpedance monitor with the 
electrodes will be done using a 1.8 mm outer diameter 
coaxial cables. 
 
 
Fig. 4.  Magnitude and phase angle of the injected current versus 
frequency for 3 load impedances (250 Ω, 980 Ω and 10 kΩ). 
 
D. Temperature measurement 
For each impedance measurement the temperature is 
recorded and saved to the system memory. This will give us 
an extra-information. The temperature measurement is done 
by the AD5933 and measures the temperature of the pig’s 
body. The increment in temperature due to the power 
dissipation has small effect on the measure and is 0.1 ºC 
maximum increment.  
 
E. RF communication 
The data are sent to the PC using a 2.4 GHz RF 
transceiver of Texas Instruments running the SimpliciTI 
protocol. SimpliciTI [11] is a low-power RF network 
protocol aimed at small RF networks and with a limited 
number of nodes talking directly to each other, it is a 
reduced version of the proprietary ZigBee protocol. The 
topology implemented is a star network, which has an access 
point (AP), an end device (ED) and a range extender (RE). 
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The AP must be always on and its main task is to form the 
network and act as a coordinator between the nodes. The ED 
is the bioimpedance monitor and sends the data to the AP. 
Also, it may accept commands from the AP to modify it 
behavior. The RE allow to increase the distance between the 
AP and the ED. It will be mounted in a harness attached to 
the skin surface of the animal. The transmitted power is -12 
dBm at a data rate of 9600 Bauds. 
 
F. Memory 
In case the radiofrequency link breaks, each impedance 
measurement is saved in a memory. The capacity of the 
memory is 16 Mbits, enough to save the data of 86 days of 
measurements. The data saved can be downloaded to the PC 
at any time. 
 
G. PC Software Application 
The data sent by the bioimpedance monitor are received 
in the computer, using another 2.4 GHz RF transceiver, 
saved and plotted in different ways to facilitate the 
interpretation. Also the application shows the received 
signal strength indication (RSSI) of the radiofrequency link 
to check the risk of losing the RF connection. 
From this application the user can change the 
measurement frequencies, perform a single measurement, 
program the measurement period, erase the memory, and 
download the data. 
 
H. Packaging 
The implantable bioimpedance monitor will be wrapped 
with cellophane film (3M) and sealed with medical-grade 
silicone (Nusil Med4011). The electrode’s cables will be 
tubed with a silicone tube and cured with epoxy (Devcon). 
III. RESULTS 
A. Electrical impedance measurements 
To study the performance of the measurement system, 
two Rp||C+Rs circuits have been used as a measurement 
load, measuring both resistance and reactance and 
comparing them with the theoretical model. The RC 
networks simulate the myocardium impedance.  
Figure 5 shows the plot of the imaginary vs real part of 
one of the Rp||C+Rs circuits with Rs = 68 Ω, Rp = 200 Ω 
and C = 82 nF.  
 
 
Fig. 5.  Impedance plot of a Rp||C+Rs circuit. Rs=68 Ω, Rp=200 Ω and 
C=82 nF. Frequency range from 100 Hz to 200 kHz. 
 
Figure 6 shows the plot of the second 2R-1C series circuit 
measured. The values are Rs = 47 Ω, Rp = 130 Ω and C = 
100 nF. 
 
 
Fig. 6.  Impedance plot of a Rp||C+Rs circuit. Rs=47 Ω, Rp=130 Ω and 
C=100 nF. Frequency range from 100 Hz to 200 kHz. 
 
The error in the estimation of the circuit resistors from the 
impedance measurements model fitting is below 0.75%. 
 
B. RF range 
Because of the big absorption of the RF signal by the 
tissues surrounding the implant at 2.4 GHz, mainly due to 
the resonance frequency of the water molecules [12], we 
perform several measurements to verify the RF range we 
would expect. The bioimpedance monitor was put into a 
plastic egg and inside a fishbowl (30 cm x 15 cm x 15 cm), 
figure 7. The fishbowl was filled with saline solution with 
conductivity of 16 mS/cm, similar that most tissues inside 
the body until the level reached 13 cm. 
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Fig. 7.  Bioimpedance monitor inside the fishbowl to measure the RF 
range of the link. 
 
The measurement consists in moving the plastic egg in the 
longitudinal direction (x) and in the depth direction (z) and 
measure the distance (y) at which the RF link gave 
communication errors. Figure 8 shows in a plot the RF link 
break distance as function of the longitudinal and depth 
direction of the plastic egg inside the fishbowl. The distance 
y exceeds 1 m when the device is close to the tank perimeter 
(x< 1 cm) and reduces to 70 cm when it is 6 cm into the 
tank.  
 
 
Fig. 8.  RF range of the link with the bioimpedance monitor immersed in 
saline solution. 
 
IV. DISCUSSION AND CONCLUSIONS 
We measured a low RF range when the bioimpedance 
monitor is immersed in a few centimeters of saline solution. 
The range we can expect in the clinical application may be 
greater because normally the implanted devices are not 
deeply inside the body but are placed transcutaneous [13]. 
With the preliminary results reported in this work it 
would be possible to implant the bioimpedance monitor to 
study the evolution of engineered tissue and transmit the 
data wirelessly using SimpliciTI, the free ZigBee protocol.  
A range extender should be placed in a harness in the animal 
surface. In order to raise the RF range without employing a 
RE, we will try to increase the sensitivity of the receiver, 
using a directional antenna with a low-noise amplifier in the 
receiver part. This point is currently investigated and will be 
reported.  
The results show the viability of real-time impedance 
spectroscopy measurements for organ or tissue monitoring 
using a telemetric device. 
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